Chemical Name: 3-(4-(((3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)amino)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
Smiles: O=C1C2=CC=CC(NC3[C@H](O)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H](CO)O3)=C2CN1C5C(NC(CC5)=O)=O
Inchi: InChI=1/C14H17N3O4/c1-21-12(18)6-5-11(13(16)19)17-7-9-8(14(17)20)3-2-4-10(9)15/h2-4,11H,5-7,15H2,1H3,(H2,16,19)
Determination of possible potential genotoxic impurities in lenalidomide drug substance by simple RP-HPLC method
By Gaddam, Kishore; Kanne, Shanker; Gundala, Trivikram Reddy; Mamilla, Yogeshwar Reddy; Chinna, Gangi Reddy Nallagondu
From Asian Journal of Chemistry (2020), 32(12), 2965-2970
Development and validation of stability-indicating RP-HPLC method for the estimation of lenalidomide and its impurities in oral solid dosage form
By Prasad, Somana Siva; Mohan, G. V. Krishna; Babu, A. Naga
From Oriental Journal of Chemistry (2019), 35(1), 140-149
Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: Application to a pharmacokinetic study
By Veeraraghavan, Sridhar; Viswanadha, Srikant; Thappali, Satheeshmanikandan; Govindarajulu, Babu; Vakkalanka, Swaroopkumar; Rangasamy, Manivannan
From Journal of Pharmaceutical and Biomedical Analysis (2015), 107, 151-158